Mimedx (MDXG) Price to Earnings (2011 - 2026)

Mimedx has disclosed Price to Earnings across 16 years of filings, most recently posting 37.81 for Q2 2026.

• In Q2 2026, Price to Earnings fell 140.23% year-over-year to 37.81; the TTM figure through Jun 2026 stood at 89.92 (up 217.95% YoY), while the FY2025 annual figure was 20.64, down 38.68% from the prior year.
• Price to Earnings came in at 37.81 for Q2 2026 at Mimedx, up from 54.17 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 190.04 in Q4 2024 to a low of 108.51 in Q1 2023.
• Average Price to Earnings over 5 years is 46.66, with a median of 59.71 recorded in 2024.
• Year-over-year, Price to Earnings sank 145.41% in 2023 and jumped 733.84% in 2024.
• Over 5 years, Price to Earnings stood at 38.86 in 2022, then sank by 41.36% to 22.79 in 2023, then jumped by 733.84% to 190.04 in 2024, then sank by 65.27% to 66.0 in 2025, then sank by 157.28% to 37.81 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 37.81 in Q2 2026, 54.17 in Q1 2026, and 66.0 in Q4 2025.